INS and diabetes mellitus: Furthermore, insulin therapy for diabetes may alter levels of certain biomarkers associated with bone metabolism, such as advanced glycation end products and other indicators related to bone density and fracture risk, thereby influencing the processes of bone formation and resorption [42].